Reddy-Dasatinib: out of specification
Last updated
Summary
Product
Reddy-Dasatinib
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Reddy-Dasatinib | Reddy-Dasatinib | DIN 02514796 | Tablet | DASATINIB (Dasatinib (S)-propylene glycol) 140 mg | ZH10018, ZH10019 |
Issue
The dissolution is out of specification in the affected lot(s).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
What is being done
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Dr. Reddy's Laboratories Canada Inc. 5580 Explorer Drive, Suite 204, Mississauga, Ontario, L4W 4Y1 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type III
Identification number
RA-63870
Get notified
Receive notifications for new and updated recalls and alerts by category.